P Schlienger

2.2k total citations
63 papers, 1.5k citations indexed

About

P Schlienger is a scholar working on Ophthalmology, Oncology and Surgery. According to data from OpenAlex, P Schlienger has authored 63 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Ophthalmology, 30 papers in Oncology and 12 papers in Surgery. Recurrent topics in P Schlienger's work include Ocular Oncology and Treatments (38 papers), Cancer and Skin Lesions (11 papers) and Cancer-related Molecular Pathways (11 papers). P Schlienger is often cited by papers focused on Ocular Oncology and Treatments (38 papers), Cancer and Skin Lesions (11 papers) and Cancer-related Molecular Pathways (11 papers). P Schlienger collaborates with scholars based in France, United States and Canada. P Schlienger's co-authors include Laurence Desjardins, J. R. Vilcoq, R Calle, J.P. Pilleron, François Doz, E. Quintana, Philippe Vielh, C Haye, Bernard Asselain and Pierre Validire and has published in prestigious journals such as Cancer, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

P Schlienger

61 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Schlienger France 20 918 515 343 300 294 63 1.5k
Corine Plancher France 22 938 1.0× 524 1.0× 125 0.4× 296 1.0× 242 0.8× 50 1.5k
Dan S. Gombos United States 22 1.2k 1.3× 624 1.2× 211 0.6× 313 1.0× 414 1.4× 87 1.9k
Jonathan W. Kim United States 26 1.4k 1.6× 447 0.9× 445 1.3× 432 1.4× 304 1.0× 87 1.9k
Theodora Hadjistilianou Italy 20 833 0.9× 317 0.6× 211 0.6× 187 0.6× 209 0.7× 90 1.2k
Lydia Komarnicky United States 22 343 0.4× 617 1.2× 465 1.4× 376 1.3× 426 1.4× 52 1.9k
Wui‐Jin Koh United States 16 438 0.5× 382 0.7× 352 1.0× 204 0.7× 344 1.2× 44 1.3k
Carol L. Shields United States 20 1.2k 1.3× 385 0.7× 186 0.5× 325 1.1× 124 0.4× 36 1.4k
Carlos Bianciotto United States 24 1.4k 1.5× 345 0.7× 129 0.4× 387 1.3× 190 0.6× 53 1.6k
Aubin Balmer Switzerland 20 1.3k 1.4× 400 0.8× 195 0.6× 472 1.6× 297 1.0× 65 1.5k
Hamid Mammar France 19 273 0.3× 133 0.3× 353 1.0× 213 0.7× 694 2.4× 60 1.5k

Countries citing papers authored by P Schlienger

Since Specialization
Citations

This map shows the geographic impact of P Schlienger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Schlienger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Schlienger more than expected).

Fields of papers citing papers by P Schlienger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Schlienger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Schlienger. The network helps show where P Schlienger may publish in the future.

Co-authorship network of co-authors of P Schlienger

This figure shows the co-authorship network connecting the top 25 collaborators of P Schlienger. A scholar is included among the top collaborators of P Schlienger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Schlienger. P Schlienger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lévy, Christine, Livia Lumbroso‐Le Rouic, F D'Hermiès, et al.. (2005). Résultats du traitement du mélanome malin de l’uvée par faisceau de protons : 10 ans de recul. Journal Français d Ophtalmologie. 28(8). 833–839. 9 indexed citations
2.
Schlienger, P, François Campana, Jacques R. Vilcoq, et al.. (2004). Nonocular Second Primary Tumors After Retinoblastoma. American Journal of Clinical Oncology. 27(4). 411–419. 13 indexed citations
3.
Aerts, Isabelle, Hélène Pacquement, François Doz, et al.. (2004). Outcome of second malignancies after retinoblastoma: a retrospective analysis of 25 patients treated at the Institut Curie. European Journal of Cancer. 40(10). 1522–1529. 64 indexed citations
4.
Rouic, Livia Lumbroso‐Le, Corinne Lévy, Corine Plancher, et al.. (2002). [Results of proton beam irradiation for treatment of choroidal melanoma].. PubMed. 25(3). 290–7. 16 indexed citations
5.
Lévy, Christine, F D'Hermiès, E Frau, et al.. (2000). [Optic neuropathy after proton-beam therapy for malignant choroidal melanoma].. PubMed. 23(6). 543–53. 14 indexed citations
6.
Soufir, Nadem, Brigitte Bressac–de Paillerets, Laurence Desjardins, et al.. (2000). Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes. British Journal of Cancer. 82(4). 818–822. 42 indexed citations
7.
Klijanienko, Jerzy, Adel K. El‐Naggar, Vincent Servois, et al.. (1999). Histologically similar, synchronous or metachronous, lacrimal salivary-type and parotid gland tumors: A series of 11 cases. Head & Neck. 21(6). 512–516. 2 indexed citations
8.
Salmon, R.J., Christine Lévy, Corine Plancher, et al.. (1998). Treatment of liver metastases from uveal melanoma by combined surgery—chemotherapy. European Journal of Surgical Oncology. 24(2). 127–130. 71 indexed citations
9.
Mazal, A., Laurent Schwartz, Hamid Mammar, et al.. (1998). A preliminary comparative treatment planning study for radiotherapy of age-related maculopathy. Radiotherapy and Oncology. 47(1). 91–98. 3 indexed citations
10.
Khelfaoui, Fatima, Pierre Validire, Anne Aupérin, et al.. (1996). Histopathologic risk factors in retinoblastoma: A retrospective study of 172 patients treated in a single institution. Cancer. 77(6). 1206–1213. 24 indexed citations
11.
Khelfaoui, Fatima, Pierre Validire, A. Aupérin, et al.. (1996). Histopathologic risk factors in retinoblastoma: A retrospective study of 172 patients treated in a single institution. American Journal of Ophthalmology. 122(1). 142–143. 48 indexed citations
12.
Schlienger, P, Jean‐Louis Habrand, L. Schwartz, et al.. (1996). Preliminary results with one-year minimum follow-up of the first 146 patients with a uveal melanoma treated with protons at CPO (Orsay). PubMed. 83. 212s–214s. 4 indexed citations
13.
Schlienger, P, et al.. (1996). External radiotherapy for carcinoma of the eyelid: Report of 850 cases treated. International Journal of Radiation Oncology*Biology*Physics. 34(2). 277–287. 29 indexed citations
14.
Habrand, J.L., P Schlienger, D. Pontvert, et al.. (1996). Clinical applications of proton therapy. PubMed. 83. 207s–211s. 6 indexed citations
15.
Jin, Yi, F. Campana, J. R. Vilcoq, et al.. (1992). [Primary epidermoid carcinoma of the breast. Clinical, histopathologic and prognostic study of 14 patients].. PubMed. 79(7). 675–9. 10 indexed citations
16.
Desjardins, Laurence, et al.. (1991). Second non-ocular tumours in survivors of bilateral retinoblastoma: A 30-year follow-up. Ophthalmic Paediatrics and Genetics. 12(3). 145–148. 30 indexed citations
17.
Bridier, A., R. Sabattier, M. Louis, et al.. (1991). [Preliminary dosimetry study of the Orsay synchrocyclotron proton beam with a view to applying it therapeutically].. PubMed. 4(1). 123–7. 1 indexed citations
18.
Campana, F., Alain Fourquet, Mark Ashby, et al.. (1989). Presentation of axillary lymphadenopathy without detectable breast primary (T0 Nib breast cancer): experience at Institut Curie. Radiotherapy and Oncology. 15(4). 321–325. 42 indexed citations
19.
Schlienger, P, et al.. (1985). [Bone sarcoma and malignant tumors of the retina].. PubMed. 72(1). 16–24. 3 indexed citations
20.
Veith, Frank J., et al.. (1977). [Basocellular epithelioma of the back with metastases of the axillary ganglia].. PubMed. 64(1). 17–30. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Corine Plancher Breakdown of academic impact, for papers by Dan S. Gombos Breakdown of academic impact, for papers by Jonathan W. Kim Breakdown of academic impact, for papers by Theodora Hadjistilianou Breakdown of academic impact, for papers by Lydia Komarnicky Breakdown of academic impact, for papers by Wui‐Jin Koh Breakdown of academic impact, for papers by Carol L. Shields Breakdown of academic impact, for papers by Carlos Bianciotto Breakdown of academic impact, for papers by Aubin Balmer Breakdown of academic impact, for papers by Hamid Mammar
Rankless by CCL
2026